Role of the Hypoxia-inducible factor-1 alpha induced autophagy in the conversion of non-stem pancreatic cancer cells into CD133+ pancreatic cancer stem-like cells

Cancer Cell International

Volumn 13, Issue 1, 2013, Pages

  Zhu, Haitao ^a   Wang, Dongqing ^a   Liu, Yanfang ^c   Su, Zhaoliang ^b   Zhang, Lirong ^a   Chen, Fangfang ^a   Zhou, Yuepeng ^a   Wu, Yingying ^a   Yu, Ming ^a   Zhang, Zhijian ^b   Shao, Genbao ^b  

^a AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

^b JIANGSU UNIVERSITY   (China)

^c First People's Hospital of Zhenjiang   (China)

Author keywords

Autophagy; HIF 1 ; Pancreatic cancer stem cell

Indexed keywords

BECLIN 1; CD133 ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; SMALL INTERFERING RNA;

ARTICLE; AUTOPHAGY; CANCER STEM CELL; CELL POPULATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTERMITTENT HYPOXIA; PANCREAS CANCER; PHENOTYPE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

EID: 84889012246     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-13-119     Document Type: Article

References (35)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012, 62(1):10-29. 10.3322/caac.20138, 22237781.
2. Lowery MA, O'Reilly EM. Pancreatic adenocarcinoma: new approaches to a challenging malignancy. Oncology (Williston Park, NY) 2010, 24(14):1339-1342.
3. Belli C, Cereda S, Anand S, Reni M. Neoadjuvant therapy in resectable pancreatic cancer: a critical review. Cancer Treat Rev 2013, 39(5):518-524. 10.1016/j.ctrv.2012.09.008, 23122322.
4. Li C, Lee CJ, Simeone DM. Identification of human pancreatic cancer stem cells. Methods Mol Biol (Clifton, NJ 2009, 568:161-173.
5. Chan KS, Volkmer JP, Weissman I. Cancer stem cells in bladder cancer: a revisited and evolving concept. Curr Opin Urol 2010, 20(5):393-397. 10.1097/MOU.0b013e32833cc9df, 2997612, 20657288.
6. Reynolds BA, Vescovi AL. Brain cancer stem cells: think twice before going flat. Cell Stem Cell 2009, 5(5):466-467. author reply 468-469, 10.1016/j.stem.2009.10.017, 19896437.
7. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003, 100(7):3983-3988. 10.1073/pnas.0530291100, 153034, 12629218.
8. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB. Identification of human brain tumour initiating cells. Nature 2004, 432(7015):396-401. 10.1038/nature03128, 15549107.
9. Boman BM, Wicha MS. Cancer stem cells: a step toward the cure. J Clin Oncol 2008, 26(17):2795-2799. 10.1200/JCO.2008.17.7436, 18539956.
10. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, Visvader J, Weissman IL, Wahl GM. Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 2006, 66(19):9339-9344. 10.1158/0008-5472.CAN-06-3126, 16990346.
11. Burness ML, Sipkins DA. The stem cell niche in health and malignancy. Semin Cancer Biol 2010, 20(2):107-115. 10.1016/j.semcancer.2010.05.006, 20510363.
12. Filatova A, Acker T, Garvalov BK. The cancer stem cell niche(s): the crosstalk between glioma stem cells and their microenvironment. Biochim Biophys Acta 2013, 1830(2):2496-2508. 10.1016/j.bbagen.2012.10.008, 23079585.
13. Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, Hamner B, Oh EY, Gaber MW, Finklestein D, Allen M, et al. A perivascular niche for brain tumor stem cells. Cancer Cell 2007, 11(1):69-82. 10.1016/j.ccr.2006.11.020, 17222791.
14. Iliopoulos D, Hirsch HA, Wang G, Struhl K. Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion. Proc Natl Acad Sci U S A 2011, 108(4):1397-1402. 10.1073/pnas.1018898108, 3029760, 21220315.
15. Hjelmeland AB, Wu Q, Heddleston JM, Choudhary GS, MacSwords J, Lathia JD, McLendon R, Lindner D, Sloan A, Rich JN. Acidic stress promotes a glioma stem cell phenotype. Cell Death Differ 2011, 18(5):829-840. 10.1038/cdd.2010.150, 3095828,3095828, 21127501.
16. Mathieu J, Zhang Z, Zhou W, Wang AJ, Heddleston JM, Pinna CM, Hubaud A, Stadler B, Choi M, Bar M, et al. HIF induces human embryonic stem cell markers in cancer cells. Cancer Res 2011, 71(13):4640-4652. 10.1158/0008-5472.CAN-10-3320, 3129496, 21712410.
17. Gopalan A, Yu W, Sanders BG, Kline K. Eliminating drug resistant breast cancer stem-like cells with combination of simvastatin and gamma-tocotrienol. Cancer Lett 2013, 328(2):285-296. 10.1016/j.canlet.2012.10.003, 23063651.
18. Xu L. Cancer stem cell in the progression and therapy of pancreatic cancer. Front Biosci (Landmark edition) 2013, 18:795-802.
19. Ribatti D. Cancer stem cells and tumor angiogenesis. Cancer Lett 2012, 321(1):13-17. 10.1016/j.canlet.2012.02.024, 22388173.
20. Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, Bruns CJ, Heeschen C. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007, 1(3):313-323. 10.1016/j.stem.2007.06.002, 18371365.
21. Kingsley LA, Fournier PG, Chirgwin JM, Guise TA. Molecular biology of bone metastasis. Mol Cancer Ther 2007, 6(10):2609-2617. 10.1158/1535-7163.MCT-07-0234, 17938257.
22. Denny WA. Hypoxia-activated prodrugs in cancer therapy: progress to the clinic. Future Oncol 2010, 6(3):419-428. 10.2217/fon.10.1, 20222798.
23. Koong AC, Mehta VK, Le QT, Fisher GA, Terris DJ, Brown JM, Bastidas AJ, Vierra M. Pancreatic tumors show high levels of hypoxia. Int J Radiat Oncol Biol Phys 2000, 48(4):919-922. 10.1016/S0360-3016(00)00803-8, 11072146.
24. Soeda A, Park M, Lee D, Mintz A, Androutsellis-Theotokis A, McKay RD, Engh J, Iwama T, Kunisada T, Kassam AB, et al. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1αlpha. Oncogene 2009, 28(45):3949-3959. 10.1038/onc.2009.252, 19718046.
25. Hashimoto O, Shimizu K, Semba S, Chiba S, Ku Y, Yokozaki H, Hori Y. Hypoxia induces tumor aggressiveness and the expansion of CD133-positive cells in a hypoxia-inducible factor-1alpha-dependent manner in pancreatic cancer cells. Pathobiology 2011, 78(4):181-192. 10.1159/000325538, 21778785.
26. Kopp HG, Avecilla ST, Hooper AT, Rafii S. The bone marrow vascular niche: home of HSC differentiation and mobilization. Physiology (Bethesda) 2005, 20:349-356. 10.1152/physiol.00025.2005, 16174874.
27. Butler JM, Kobayashi H, Rafii S. Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors. Nat Rev Cancer 2010, 10(2):138-146. 10.1038/nrc2791, 2944775, 20094048.
28. Liang D, Ma Y, Liu J, Trope CG, Holm R, Nesland JM, Suo Z. The hypoxic microenvironment upgrades stem-like properties of ovarian cancer cells. BMC Cancer 2012, 12:201. 10.1186/1471-2407-12-201, 3407800, 22642602.
29. Higgins LH, Withers HG, Garbens A, Love HD, Magnoni L, Hayward SW, Moyes CD. Hypoxia and the metabolic phenotype of prostate cancer cells. Biochim Biophys Acta 2009, 1787(12):1433-1443. 10.1016/j.bbabio.2009.06.003, 19524545.
30. Keith B, Johnson RS, Simon MC. HIF1alpha and HIF2alpha: sibling rivalry in hypoxic tumour growth and progression. Nat Rev Cancer 2011, 12(1):9-22. 3401912, 22169972.
31. Semenza GL. Hypoxia-inducible factors in physiology and medicine. Cell 2012, 148(3):399-408. 10.1016/j.cell.2012.01.021, 3437543, 22304911.
32. Jin S, White E. Role of autophagy in cancer: management of metabolic stress. Autophagy 2007, 3(1):28-31. 2770734, 16969128.
33. Mizushima N, Levine B, Cuervo AM, Klionsky DJ. Autophagy fights disease through cellular self-digestion. Nature 2008, 451(7182):1069-1075. 10.1038/nature06639, 2670399, 18305538.
34. Chaachouay H, Ohneseit P, Toulany M, Kehlbach R, Multhoff G, Rodemann HP. Autophagy contributes to resistance of tumor cells to ionizing radiation. Radiother Oncol 2011, 99(3):287-292. 10.1016/j.radonc.2011.06.002, 21722986.
35. Li L, Chen Y, Gibson SB. Starvation-induced autophagy is regulated by mitochondrial reactive oxygen species leading to AMPK activation. Cell Signal 2013, 25(1):50-65. 10.1016/j.cellsig.2012.09.020, 23000343.